Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Regulatory securities lawsuit

PROCEPT BioRobotics Securities Fraud Class Action

Analysis based on 140 articles · First reported Aug 03, 2026 · Last updated Sep 22, 2026

Sentiment
-15
Attention
2
Articles
140
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The class action lawsuits create legal and reputational risk for PROCEPT BioRobotics, potentially leading to financial penalties and further stock price volatility as litigation progresses. The broader medical device sector may face increased investor scrutiny regarding sales practices and inventory management disclosures, though the impact is largely company-specific.

medical devices legal services healthcare

Multiple law firms have filed securities class action lawsuits against PROCEPT BioRobotics Corporation (NASDAQ: PRCT) on behalf of investors who purchased or acquired the company's securities between February 28, 2024 and February 25, 2026. The complaints allege that PROCEPT and certain executives made materially false and misleading statements regarding the company's business, operations, and financial condition. Specifically, the lawsuits claim PROCEPT used an undisclosed discount program to incentivize customers to place bulk handpiece orders exceeding procedure demand, artificially inflating reported U.S. handpiece unit sales and revenues by pulling forward sales from future periods. This allegedly created excess field inventory and overstocking among customers, totaling more than 10,000 excess units by the end of the Class Period. The company's stock price declined significantly following a series of partial disclosures: approximately 16% after Q2 2025 earnings on August 6, 2025, more than 10% after Q3 2025 results on November 4, 2025, and more than 18% after Q4 2025 results on February 25, 2026. The lead plaintiff deadline is September 22, 2026. The case is pending in the United States — United States District Court for the Northern District of California as Operating Engineers Construction Industry and Miscellaneous Pension Fund v. PROCEPT BioRobotics Corporation, No. 26-cv-07691. Law firms involved include Pomerantz LLP, Glancy Prongay & Murray, Kahn Swick & Foti LLC, Rosen Law Firm, Kaplan Fox & Kilsheimer, Hagens Berman, and the Law Offices of Howard G. Smith.

100 Levi & Korsinsky filed securities class action PROCEPT BioRobotics
95 Hagens Berman filed class action PROCEPT BioRobotics
90 Rosen Law Firm filed class action PROCEPT BioRobotics
90 Rosen Law Firm filed securities class action PROCEPT BioRobotics
85 PROCEPT BioRobotics disclosed excess field inventory
85 PROCEPT BioRobotics missed revenue guidance
83 PROCEPT BioRobotics missed sales guidance
80 Pomerantz LLP filed class action PROCEPT BioRobotics
80 Glancy Prongay & Murray filed securities fraud lawsuit PROCEPT BioRobotics
80 Hagens Berman filed class action PROCEPT BioRobotics
80 PROCEPT BioRobotics reduced handpiece guidance
80 PROCEPT BioRobotics reported Q2 results
80 Pomerantz LLP filed class action PROCEPT BioRobotics
+ 46 more actions View on Dashboard
stock
The central defendant in the securities fraud class action, facing allegations of misleading investors about handpiece sales and inventory practices. The litigation and associated stock declines of over 48% from August 2025 to February 2026 pose significant financial and reputational risks.
Importance 100.0 Sentiment -40.0
priv
A lead plaintiffs' law firm that filed the class action against PROCEPT and is actively soliciting investors to join before the September 22, 2026 deadline.
Importance 60.0 Sentiment 0.0
priv
A global investor rights law firm that filed a class action against PROCEPT and is reminding investors of the September 22, 2026 deadline.
Importance 55.0 Sentiment 0.0
priv
Filed a securities fraud class action against PROCEPT and is reminding investors of the lead plaintiff deadline.
Importance 55.0 Sentiment 0.0
priv
Filed a securities class action against PROCEPT and is urging investors with substantial losses to seek lead plaintiff appointment.
Importance 55.0 Sentiment 0.0
priv
Filed a class action lawsuit against PROCEPT and is notifying investors of the lead plaintiff deadline.
Importance 55.0 Sentiment 0.0
priv
Filed a securities class action against PROCEPT and is investigating claims regarding the company's sales practices and disclosures.
Importance 50.0 Sentiment 0.0
per
PROCEPT's Chief Financial Officer who provided guidance and disclosed inventory issues during earnings calls, and is named as a defendant in the class action.
Importance 35.0 Sentiment -20.0
per
CEO of PROCEPT who admitted to inventory management issues during earnings calls, and is named as a defendant.
Importance 30.0 Sentiment -20.0
govactor
The court where the securities class action against PROCEPT is pending.
Importance 25.0 Sentiment 0.0
per
Former CEO of PROCEPT who announced the elimination of the Chief Commercial Officer role during the Class Period.
Importance 25.0 Sentiment -15.0
exch
The exchange where PROCEPT BioRobotics shares (PRCT) are traded and have experienced significant declines.
Importance 20.0 Sentiment 0.0
per
Former Louisiana Attorney General and partner at Kahn Swick & Foti, involved in the class action against PROCEPT.
Importance 20.0 Sentiment 0.0
per
Managing partner at Kahn Swick & Foti, representing investors in the class action against PROCEPT.
Importance 20.0 Sentiment 0.0
per
Hagens Berman partner leading the firm's investigation into PROCEPT's sales practices.
Importance 20.0 Sentiment 0.0
+ 10 more entities View on Dashboard
Pomerantz LLP co-plaintiff ↔ Rosen Law Firm Pomerantz LLP frequently acts as a co-plaintiff with Rosen Law Firm in numerous investor-rights class action lawsuits ag
Pomerantz LLP co-litigator ↔ Glancy Prongay & Murray Pomerantz LLP often works alongside Glancy Prongay & Murray as co-plaintiffs in securities fraud class actions, pursuing
Pomerantz LLP co-counsel ↔ Kaplan Fox & Kilsheimer Pomerantz LLP frequently acts as co-counsel with Kaplan Fox & Kilsheimer in various securities class action lawsuits, re
Pomerantz LLP co-counsel ↔ Hagens Berman Pomerantz LLP frequently acts as co-counsel with Hagens Berman in various securities fraud and class action lawsuits, re
+ 18 more relationships View on Dashboard
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.